Medtecs Group announced on 11 August 2020 its half-year financial results for the period ended 30 June 2020.The Group’s revenue increased significantly by 390.5% from US$33.2 million in 1H19 to US$162.6 million in 1H20 from increase in demand of personal protective apparels due to the COVID-19 global pandemic; which also raised awareness on healthcare products and led to increase in sales from our existing customers.

CEO William Yang has shown his confidence in the company by scooping up his first holdings in Medtecs shares. AS nations struggled to deal with the COVID-19 crisis earlier this year, MedTecs International Corp. – a Singapore-listed maker of surgical masks, medical coveralls and isolation gowns -was turning away orders for its products.

Medtecs Group recently was featured in 10-in-10, which is a research newsletter launched in 2019 by the Singapore Stock Exchange. 
In the links below you will find the Group’s business objectives, key revenue drivers, future plans as well as the industry landscape presented and discussed in detail.

MEDTECS International is planning to transfer the company’s listing from the Catalist to the mainboard of the Singapore Exchange (SGX), it said on Monday. Separately, Medtecs also announced that the group will be included in the MSCI Singapore Small Cap Index from Nov 30, after the market close on that day.